Skip to main content
. 2012 Sep 18;2(5):e001413. doi: 10.1136/bmjopen-2012-001413

Table 4.

Association of sleep medication use with outcomes other than mortality

Age adjusted
Adjusted for age +3 primary confounders
Outcome Hypnotic use 5+/week
Hypnotic use 5+/week
 HR χ2** CI
HR χ2** CI
Myocardial infarction 1.35 21.7 1.19 1.53 1.02 0.05 0.89 1.15
Stroke 1.35 18.1 1.17 1.54 1.09 1.5 0.95 1.25
Diabetes 1.17 14.9 1.08 1.27 0.85 15.4 0.78 0.92
Breast cancer 1.11 3.7 1.00 1.22 1.12 4.7 1.01 1.24
Colon cancer 0.70 6.4 0.53 0.92 0.64 9.7 0.49 0.85
Lung cancer 1.58 20.6 1.30 1.92 1.17 2.3 0.96 1.43
Colorectal cancer 0.71 6.8 0.55 0.92 0.66 10.2 0.51 0.85
Lymphoma 1.09 0.3 0.79 1.52 1.04 0.05 0.74 1.45
Melanoma 1.35 5.2 1.04 1.74 1.53 10.4 1.18 1.99
Ovary cancer 0.94 0.1 0.65 1.36 0.93 0.1 0.64 1.36

*If χ2 ≥ 9.5, p<0.05. If χ2 ≥ 22.7, p<0.0001.

**If χ2 ≥ 3.84, p<0.05. If χ2 ≥ 14.4, p<0.0001.